Tivdak Disease Interactions
There are 3 disease interactions with Tivdak (tisotumab vedotin).
Tisotumab vedotin (applies to Tivdak) hepatic impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Avoid the use of tisotumab vedotin in patients with moderate or severe hepatic impairment.
Tisotumab vedotin (applies to Tivdak) ocular toxicity
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Visual Defect/Disturbance
Ocular adverse events are very common in patients receiving treatment with tisotumab vedotin. Patients with baseline visual disturbances should be monitored and if any symptoms worsen should be evaluated promptly by an eye care provider. Reduce dosage, withhold or permanently discontinue treatment based on the severity of the symptoms.
Tisotumab vedotin (applies to Tivdak) peripheral neuropathy
Moderate Potential Hazard, Moderate plausibility.
Patients receiving treatment with tisotumab vedotin may have peripheral neuropathy adverse reactions. Patients with preexisting peripheral neuropathy should be monitored. Reduce dosage, withhold, or permanently discontinue treatment based on the severity of symptoms.
Switch to professional interaction data
Tivdak drug interactions
There are 321 drug interactions with Tivdak (tisotumab vedotin).
Report options
More about Tivdak (tisotumab vedotin)
- Tivdak consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Zirabev
Zirabev is used for cervical cancer, colorectal cancer, fallopian tube cancer, glioblastoma ...
Ifosfamide
Ifosfamide systemic is used for cancer, cervical cancer, testicular cancer
Cyclophosphamide
Cyclophosphamide systemic is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia ...
Bevacizumab
Bevacizumab injection is a targeted cancer drug used to treat types of non-small cell lung cancer ...
Fluorouracil
Fluorouracil systemic is used for anal cancer, breast cancer, breast cancer, palliative, cancer ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
